Using it for anything else, including chronic weight management in people without diabetes, is considered 'off-label.' Insurance companies are built on risk management and cost control
Dihexa appears in research contexts involving HGF/c-Met pathway research, neurotrophic signaling models, cognitive pathway studies
It now includes oral GLP-1 drugs, amylin combinations, dual agonists, triple agonists, long-acting platforms, and differentiated assets designed for durability, tolerability, access, or broader metabolic indications
January 23rd, 2024 2 min read GLP-1, originally developed to treat diabetes, also works as a weight loss medication as well
The compounded semaglutide guide addresses this transition in depth
That said, a third-party psychiatric consultant or therapist may provide additional services